EUVIMEDEUVIMED entdecken
Crossref

Biocatalytic, asymmetric radical hydrogenation of unactivated alkenes

Jaicy Vallapurackal iD, Rajib Mandal iD, Justin Bossenbroek iD, Aris V Rubio iD, Ethan Poladian iD, James D Collings iD, Cesar Torres iD, Matthew Hendrickson, Julian Morales iD, Max B Lyons iD, Kyle Schultz iD, Hannah S Shafaat iD und 2 weitere

Science · 04.12.2025 · 390 (6777) · 1050-1056

DOI: 10.1126/science.aea4737 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, erschienen am 04.12.2025. Verfasst von Jaicy Vallapurackal und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of California Los Angeles, Los Angeles, CA, USA. Hauptthemen laut MEDLINE: Alkenes. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 125 Literaturangaben. Gefördert von: University of California, Los Angeles.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alkene hydrogenation is a cornerstone of chemical synthesis, yet enzymatic strategies remain limited to electron-deficient substrates by means of hydride transfer. Using heme enzymes, we unlock a hydrogenation pathway for the asymmetric reduction of unactivated olefins. A silane-promoted heme-cysteine redox cycle in the active site catalyzes sequential hydrogen atom transfer to challenging scaffolds, including 1,1-disubstituted as well as tri- and tetrasubstituted alkenes. The evolved enzymes are promiscuous and oxygen tolerant, use Earth-abundant iron, and can operate on the gram scale under ambient conditions. Orthogonal hydrogen atom sources enable site-divergent asymmetric isotope labeling. Mechanistic and computational studies support a stepwise radical process. Our work introduces a biochemical approach for stereoselective olefin reduction and provides a platform for next-generation biocatalytic hydrogenation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlkenesHydrogenationBiocatalysisOxidation-ReductionHemeCysteineCatalytic DomainHydrogen

Substanzen

AlkenesHemeCysteineHydrogen

Autor:innen und Institutionen

  • Department of Chemistry and Biochemistry, University of California Los Angeles, Los Angeles, CA, USA.

ORCID-Profile: Jaicy Vallapurackal, Rajib Mandal, Justin Bossenbroek, Aris V Rubio, Ethan Poladian, James D Collings, Cesar Torres, Julian Morales, Max B Lyons, Kyle Schultz, Hannah S Shafaat, K N Houk, Soumitra V Athavale

Förderung

  • University of California, Los Angeles

Zitieren

APA

Vallapurackal, J., Mandal, R., Bossenbroek, J., Rubio, A. V., Poladian, E., Collings, J. D., Torres, C., Hendrickson, M., Morales, J., Lyons, M. B., Schultz, K., Shafaat, H. S., Houk, K. N., & Athavale, S. V. (2025). Biocatalytic, asymmetric radical hydrogenation of unactivated alkenes. Science, 390(6777), 1050-1056. https://doi.org/10.1126/science.aea4737

Vancouver

Vallapurackal J, Mandal R, Bossenbroek J, Rubio AV, Poladian E, Collings JD, et al. Biocatalytic, asymmetric radical hydrogenation of unactivated alkenes. Science. 2025;390(6777):1050-1056. doi:10.1126/science.aea4737

BibTeX
@article{Vallapurackal2025,
  author = {Vallapurackal, Jaicy and Mandal, Rajib and Bossenbroek, Justin and Rubio, Aris V and Poladian, Ethan and Collings, James D and Torres, Cesar and Hendrickson, Matthew and Morales, Julian and Lyons, Max B and Schultz, Kyle and Shafaat, Hannah S and Houk, K N and Athavale, Soumitra V},
  title = {Biocatalytic, asymmetric radical hydrogenation of unactivated alkenes},
  journal = {Science},
  year = {2025},
  volume = {390},
  number = {6777},
  pages = {1050--1056},
  doi = {10.1126/science.aea4737}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche